Back to search
Central Nervous System Tumor, Pediatric
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Central Nervous System Tumor, Pediatric trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Central Nervous System Tumor, Pediatric trials you may qualify forThe purpose of this research study is to learn about the safety and feasibility of giving a personalized DNA vaccine to people with central nervous system tumor…
This is a pilot project to explore the utility of PET-MRI in the post-treatment surveillance of high-grade gliomas or medulloblastomas in children in our instit…
The purpose of this study is to find out whether selinexor is an effective treatment for people who have a relapsed/refractory Wilms tumor, rhabdoid tumor, MPNS…
Purpose : the aim of this study is to assess the feasibility and safety of ultrasound-induced opening of the blood-brain barrier (BBB) with the SonoCloud-9 impl…
Loc3CAR is a Phase I clinical trial evaluating the use of autologous B7-H3-CAR T cells for participants ≤ 21 years old with primary CNS neoplasms. B7-H3-CAR T c…
A roll-over study to assess long-term effect in pediatric patients treated with dabrafenib and/or trametinib.
An early phase 1 for pediatric patients with recurrent or progressive CNS malignancies
BACKGROUND: * Despite progress, some children and young adults with solid tumors still experience poor survival. * Activated NK cells potently kill autologous…
This study is researching an experimental drug called cemiplimab (called "study drug") and the combination of experimental drugs of fianlimab and cemiplimab (ca…